DAX rallies ahead of Yellen speech

The German equity market has jumped over 1% ahead of the announcement from Janet Yellen at 3pm (London time).

The DAX is trading at 9410, up 1.25%, as traders get their long positions in place before Ms Yellen makes her first testimony before Congress. In January, Ben Bernanke’s term as chairman of the Federal Reserve came to an end. During his tenure unemployment dropped to a five-year low and he trimmed the stimulus package. As Ms Yellen is known to prefer more stimulus to less, dealers are speculating if she will want to avoid tapering for the next few months.

Ms Yellen will engage in a question-and-answer session from 3pm (London time) and traders will be listening for any clues about what her intention is in relation to the quantitative easing scheme. There are no other major economic announcements expected today so all focus will be on Ms Yellen.

As Alastair McCaig mentioned, the DAX is above the support line of 9102, and if Ms Yellen states the US economy is not ready for additional tapering it could put the recent highs of 9700 in sight.

Germany 30 chart

This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.